Carregant...
B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies
Outcomes of patients with multiple myeloma (MM) who become refractory to standard therapies are particularly poor and novel agents are greatly needed to improve outcomes in such patients. B-cell maturation antigen (BCMA) has become an important therapeutic target in MM with three modalities of treat...
Guardat en:
| Publicat a: | Ther Adv Hematol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7970693/ https://ncbi.nlm.nih.gov/pubmed/33796236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620721989585 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|